-
EP0850059
European procedure
Extract from the Register of European Patents
EP About this file: EP0850059
| EP0850059 - PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACIN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.01.2004 Database last updated on 22.08.2024 | Most recent event Tooltip | 02.01.2004 | No opposition filed within time limit | published on 18.02.2004 [2004/08] | Applicant(s) | For all designated states Novartis International Pharmaceutical Ltd. Hurst Holme, 12 Trott Road Hamilton HM 11 / BM | [N/P] |
| Former [2003/40] | For all designated states Novartis International Pharmaceutical Ltd. Hurst Holme, 12 Trott Road Hamilton HM 11 / BM | ||
| Former [2003/09] | For:AT
BE
CH
DE
DK
ES
FI
FR
GR
IE
IT
LI
LU
NL
PT
SE
Pfizer Research and Development Company, N.V./S.A. La Touche House, International Financial Services Centre Dublin 1 / IE | ||
| For:GB
Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ / GB | |||
| Former [1998/27] | For:AT
BE
CH
DE
DK
ES
FI
FR
GR
IE
IT
LI
LU
NL
PT
SE
Pfizer Research and Development Company, N.V./S.A. La Touche House, International Financial Services Centre Dublin 1 / IE | ||
| For:GB
Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB | Inventor(s) | 01 /
DOLAN, Thomas, Francis Pfizer Central Research Ramsgate Road Sandwich Kent CT13 9NJ / GB | 02 /
HUMPHREY, Michael, John Pfizer Central Research Ramsgate Road Sandwich Kent CT13 9NJ / GB | 03 /
NICHOLS, Donald, John Pfizer Central Research Ramsgate Road Sandwich Kent CT13 9NJ / GB | [1998/27] | Representative(s) | Crawley, Patrick Edward, et al Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach 4002 Basel / CH | [N/P] |
| Former [2003/40] | Crawley, Patrick Edward, et al Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach 4002 Basel / CH | ||
| Former [1998/27] | Hayles, James Richard, et al Pfizer Limited, Patents Department, Ramsgate Road Sandwich Kent CT13 9NJ / GB | Application number, filing date | 96930085.4 | 21.08.1996 | [1998/27] | WO1996EP03719 | Priority number, date | GB19950018953 | 15.09.1995 Original published format: GB 9518953 | [1998/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9709980 | Date: | 20.03.1997 | Language: | EN | [1997/13] | Type: | A1 Application with search report | No.: | EP0850059 | Date: | 01.07.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.03.1997 takes the place of the publication of the European patent application. | [1998/27] | Type: | B1 Patent specification | No.: | EP0850059 | Date: | 26.02.2003 | Language: | EN | [2003/09] | Search report(s) | International search report - published on: | EP | 20.03.1997 | Classification | IPC: | A61K31/40, A61K9/16, A61K9/20, A61K47/48 | [1998/27] | CPC: |
A61K9/2018 (EP,US);
A61K31/40 (EP,KR,US);
A61K31/4025 (EP,US);
A61K9/16 (KR);
A61K9/1611 (EP,US);
A61K9/1652 (EP,US);
A61K9/20 (KR);
A61K9/2009 (EP,US);
A61K9/2054 (EP,US);
A61K9/5047 (EP,US);
A61P1/00 (EP);
A61P1/12 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
A61P15/00 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1998/27] | Title | German: | DARIFENACIN ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN | [1998/27] | English: | PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACIN | [1998/27] | French: | FORMULATIONS PHARMACEUTIQUES CONTENANT DE LA DARIFENACINE | [1998/27] | Entry into regional phase | 28.01.1998 | National basic fee paid | 28.01.1998 | Designation fee(s) paid | 28.01.1998 | Examination fee paid | Examination procedure | 21.01.1997 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.01.1998 | Examination requested [1998/27] | 30.04.2001 | Despatch of a communication from the examining division (Time limit: M04) | 30.06.2001 | Reply to a communication from the examining division | 28.09.2001 | Despatch of a communication from the examining division (Time limit: M04) | 23.01.2002 | Reply to a communication from the examining division | 26.03.2002 | Despatch of communication of intention to grant (Approval: No) | 26.07.2002 | Despatch of communication of intention to grant (Approval: later approval) | 30.08.2002 | Communication of intention to grant the patent | 18.11.2002 | Fee for grant paid | 18.11.2002 | Fee for publishing/printing paid | Divisional application(s) | EP02015165.0 / EP1245231 | Opposition(s) | 27.11.2003 | No opposition filed within time limit [2004/08] | Fees paid | Renewal fee | 04.07.1998 | Renewal fee patent year 03 | 02.07.1999 | Renewal fee patent year 04 | 30.06.2000 | Renewal fee patent year 05 | 03.07.2001 | Renewal fee patent year 06 | 04.07.2002 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]EP0388054 (PFIZER LTD [GB], et al) [AD] 1-19 * claims 1,8-12 * * page 7, line 8 - line 24 *; | [A]WO9519164 (PFIZER LTD [GB], et al) [A] 1-19 * claims 2-6 * * page 1, line 30 - line 31 * * page 2, line 8 - line 10 ** page 3, line 10 - line 26 * |